1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 10085782 2024-04-01 2025-03-31 10085782 2025-03-31 10085782 2024-03-31 10085782 2023-04-01 2024-03-31 10085782 2024-03-31 10085782 2023-03-31 10085782 bus:Director1 2024-04-01 2025-03-31 10085782 core:WithinOneYear 2025-03-31 10085782 core:WithinOneYear 2024-03-31 10085782 core:ShareCapital 2025-03-31 10085782 core:ShareCapital 2024-03-31 10085782 core:RetainedEarningsAccumulatedLosses 2025-03-31 10085782 core:RetainedEarningsAccumulatedLosses 2024-03-31 10085782 bus:SmallEntities 2024-04-01 2025-03-31 10085782 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10085782 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10085782 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10085782 bus:FullAccounts 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 10085782
HEC Pharm UK Limited
Filleted Unaudited Financial Statements
31 March 2025
HEC Pharm UK Limited
Statement of Financial Position
31 March 2025
2025
2024
Note
£
£
Current assets
Debtors
5
19,016
9,000
Cash at bank and in hand
52,327
--------
-------
71,343
9,000
Creditors: amounts falling due within one year
6
241,186
8,661
---------
-------
Net current (liabilities)/assets
( 169,843)
339
---------
----
Total assets less current liabilities
( 169,843)
339
---------
----
Net (liabilities)/assets
( 169,843)
339
---------
----
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss account
( 170,843)
( 661)
---------
-------
Shareholders (deficit)/funds
( 169,843)
339
---------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 23 December 2025 , and are signed on behalf of the board by:
Mr S Thakkar
Director
Company registration number: 10085782
HEC Pharm UK Limited
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The Old Mill, 9 Soar Lane, Leicester, LE3 5DE.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: Nil).
5. Debtors
2025
2024
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
9,000
9,000
Other debtors
10,016
--------
-------
19,016
9,000
--------
-------
6. Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
8,305
Amounts owed to group undertakings and undertakings in which the company has a participating interest
140,000
Corporation tax
624
624
Other creditors
92,257
8,037
---------
-------
241,186
8,661
---------
-------
During the year the company was provided with interest free loans from unrelated parties totalling £37,500 (2024: NIL), these amounts are included within other creditors
7. Going concern
At 31 March 2025 the company's liabilities exceed its assets by £177,880 (2024: NIL). The company's parent company HEC (HongKong) Holding Co. Limited and the directors have stated that they will continue to financially support the company to enable it to continue trading for the foreseeable future.
8. Controlling party
The company is controlled by HEC (HongKong) Sales Co. Limited, a company incorporated in the HongKong, which is the immediate controlling party. Its registered office is located at Room 06, 13A/F South Tower World Finance Centre, Harbour City, 17 Canton Road, Tst Kln.